Browse Obstetrics/Gynecology Articles by Topic

For Methods that are Reversible and Long-acting, the Upswing Continues

Our annual contraception survey shows “dramatically more” women choosing intrauterine and implant contraception.

Use of Cervical Length and Fetal Fibronectin in Preterm Labor

SYNOPSIS: A large 10-center study has validated the concept of screening all patients who are presenting with preterm contractions in the third trimester with cervical length examinations by transvaginal sonography and using fetal fibronectin selectively only in those with cervical lengths between 1.5 and 3.0 cm.

OB/GYN Clinical Alert - Full November 2014 Issue in PDF

Does Single or Double Insemination During Ovulation Induction Cycle Increase Pregnancy Rates?

Synopsis: Performing intrauterine insemination with the use of donor sperm twice during a natural or stimulated ovulation induction cycle did not increase pregnancy rates over a single insemination.

Swedish Case-control Study Sees Increase in DVT Risk with DMPA: Is This Real?

Synopsis: A large case-control study done in Sweden that evaluated thromboembolic complications in users of hormonal contraception found an increased risk in users of depomedroxyprogesterone acetate and the combined pill. Desogestrel-containing oral contraceptives showed an increase in risk relative to levonorgestrel pills.

Preventing Pertussis: Are Your Patients and Their Families Cocooning

SYNOPSIS: Prior vaccination of both parents with Tdap (¡°cocooning¡±) protects newborn infants from contracting pertussis.

Internal Medicine Alert - Full October 15, 2014 Issue in PDF

Do Telephone- and Internet-based Communications with Patients Increase Office Visits?

In an integrated health plan and care delivery system, before and after a medical home redesign, proportional increases in copay-free secure messaging and telephone encounters were associated with additional primary care office visits for individuals with diabetes.

Naltrexone HCl and Bupropion HCl Extended-Release Tablets (Contrave ® )

The FDA has approved another drug combination for the treatment of chronic weight management, combining two old drugs, naltrexone and bupropion, in a fixed combination. Naltrexone is an opioid antagonist and bupropion is a commonly prescribed antidepressant.

Does It Really Make a Difference What Weight-Reduction Diet You Choose?

Since two-thirds of American adults are currently overweight or obese, we would all like to be able to help patients choose the best diet. The list of choices and categories is lengthy, with vocal advocates for the Atkins diet, the Zone diet, South Beach diet, Jenny Craig, Ornish, etc. Of course, were any of these diets sufficiently effective and easily adopted that they could gain widespread advocacy, we wouldnt be faced with such an obesity epidemic in the first place! So, apparently there is no simple answer. Among the choices we have, then, which one might be the best?